메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

에어스메디컬, SwiftMR® 대대적인 업데이트 발표 - MRI 운영 자율성 대폭 향상

서울, 대한민국, 2025년 7월 15일 -- AI 기반 진단 영상 솔루션 선도 기업인 에어스메디컬(AIRS Medical)이 오늘 SwiftMR의 대대적인 업데이트1를 발표했다. SwiftMR은 MRI 촬영 시간을 최대 50% 2 단축하면서 영상 품질을 향상시키는 소프트웨어다. 이번 최신 버전은 의료진에게 더 큰 유연성과 자율성을 제공할 수 있도록 설계된 새로운 기능들을 포함하고 있다. 영상팀의 운영 자율성 대폭 향상 에어스메디컬은 이번 업데이트를 통해 사용자에게 그 어느 때보다 강력한 통제 권한을 부여한다. 임상팀은 이제 SwiftMR 내에서 직접 스캔 설정을 개인화하는 방법을 교육받아 활용할 수 있다. 이를 통해 의료 시스템과 엔터프라이즈 네트워크 전반에서 영상 표준화가 가능해진다. 이제 사용자는 임상적 요구에 따라 영상 설정을 조정하고, 신체 부위별로 프로토콜을 정밀하게 조정하며, 즉시 독립적으로 변경 사항을 적용할 수 있는 자율성을 갖추게 됐다. 이번 업데이트에는 다음과 같은 주요 개선 사항이 적용됐다. 보안 업그레이드 – 더 강력한 암호 정책, 다단계 인증, 더 스
- 김갑성 기자
- 2025-07-15 18:00
Argon Medical Streamlines Distribution of Product and Enhances Customer Training for Europe, Asia, and Africa with the Debut of a Modern, Mixed-Use Facility

PLANO, Texas, July 15, 2025 -- Argon Medical, a leading provider of medical device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology procedures, announces the grand opening of its new Distribution & Education Center (ADEC), strategically located in Derby, United Kingdom. This state-of-the-art facility represents a major step forward in the company's global operations, serving as a dedicated hub for over 80 countries across Europe, Africa, the Middle East (EMEA), and Asia-Pacific (APAC) regions. Spanning more than 20,0
- 김갑성 기자
- 2025-07-15 17:12
Youthful Narrative Bridges Traditional Chinese Medicine to Global Audience

LIAOCHENG, China, July 15, 2025 -- Amidst global challenges in chronic disease prevention and health management, Traditional Chinese Medicine (TCM)'s core principles of "preventive treatment of disease" (zhi wei bing, 治未病) and "harmony between humanity and nature" (tian ren he yi, 天人合一) are gaining international attention. The TCM cultural program The Young TCM Masters, co-produced by Dong-E-E-Jiao Co., Ltd, Shandong Radio and TV station, and Tencent Video, has achieved 5 billion online impressions through its innovative youth-oriented narrative. The program dismant
- 김갑성 기자
- 2025-07-15 16:45
AXA and China Biotech Services Sign Memorandum of Understanding

[ 메디채널 김갑성 기자 ] Joint effort to explore innovative cancer treatment solutions and broaden options for customers HONG KONG, July 15, 2025 -- AXA China Region Insurance Company (Bermuda) Limited, together with AXA International Reinsurance (Shanghai) Company Limited ("AXA"), is pleased to announce the signing of a strategic Memorandum of Understanding (MoU) with China Biotech Services Holdings Limited ("China Biotech Services"). The collaboration aims to explore innovative cancer treatment technologies, including Boron Neutron Capture Therapy ("BNCT") and
- 김갑성 기자
- 2025-07-15 15:23
The Westin Singapore Presents "Mind Over Miles" Fireside Chat to Celebrate Third Year with Standard Chartered Singapore Marathon

[ 메디채널 황정호 기자 ] A fireside chat with Natalie Dau and Gregory Pink, part of the "One Race, Many Journeys" campaign SINGAPORE, July 15, 2025 -- In celebration of our third year as the Official Elite Hotel of the Standard Chartered Singapore Marathon, The Westin Singapore proudly presents "One Race, Many Journeys: Mind Over Miles" — an inspiring evening of conversation, movement, and community with ultramarathoner, author, and motivational speaker, Natalie Dau, and Singapore-based personal trainer, Gregory Pink. This event is part of our "One Race, Many Journey
- 황정호 기자
- 2025-07-15 15:06
Baraya Extended Care Closes Series B Funding Round Bringing Total Capital Raised to USD 124 Million from TVM Capital Healthcare and a Syndicate of Prominent Investors

TVM Capital Healthcare's oversubscribed fundraise for Baraya Extended Care addresses critical gaps in long-term care, supporting Saudi Arabia's Vision 2030 healthcare goals. DUBAI, UAE and RIYADH, Saudi Arabia, July 15, 2025 -- TVM Capital Healthcare announces the closing of a Series B fundraising, surpassing its target and bringing the total capital raised to USD 124 million for Baraya Extended Care ["Baraya"], a leading provider of long-term care and rehabilitation services in Saudi Arabia. This fundraise comes at a critical moment, as Saudi Arabia faces a
- 김갑성 기자
- 2025-07-15 14:00
Baraya Extended Care Closes Series B Funding Round Bringing Total Capital Raised to USD 124 Million from TVM Capital Healthcare and a Syndicate of Prominent Investors

TVM Capital Healthcare's oversubscribed fundraise for Baraya Extended Care addresses critical gaps in long-term care, supporting Saudi Arabia's Vision 2030 healthcare goals. DUBAI, UAE and RIYADH, Saudi Arabia, July 15, 2025 -- TVM Capital Healthcare announces the closing of a Series B fundraising, surpassing its target and bringing the total capital raised to USD 124 million for Baraya Extended Care ["Baraya"], a leading provider of long-term care and rehabilitation services in Saudi Arabia. This fundraise comes at a critical moment, as Saudi Arabia faces a
- 김갑성 기자
- 2025-07-15 14:00
Divamics' AI and Molecular Dynamics Platform Powers Breakthroughs in Metabolic Disease Drug Discovery for Partners

SUZHOU, China, July 15, 2025 -- Divamics, a pioneer in AI-driven drug discovery, highlighted its critical role in advancing metabolic disease therapeutics through its advanced AI and molecular dynamics(MD) platform. This powerful platform recently supported the successful design of BGM1812, a novel dual AMY3R/CTR receptor agonist for obesity treatment, as published in the July 2025 issue of the Journal of Medicinal Chemistry. This achievement underscores Divamics' consistent ability to empower its partners in accelerating their drug discovery pipelines. AI-Powered Efficiency & Pre
- 김갑성 기자
- 2025-07-15 07:31
Ascletis Completes Dosing of All Participants in Its U.S. Clinical Study Combining Adipose-Targeted, Once-Monthly Injectable Small Molecule THRβ Agonist, ASC47, and Semaglutide for the Treatment of Obesity

- The combination study, conducted in the U.S., is designed to evaluate the safety, tolerability and preliminary efficacy at Day 29 of a single-dose of ultra-long-acting subcutaneously administered ASC47 (half-life up to 40 days) in combination with four doses of semaglutide (0.5 mg, once weekly) in 28 participants with obesity. - Initiated in May 2025, all 28 participants were enrolled in less than two months. - Topline data are expected in the fourth quarter of 2025. HONG KONG, July 15, 2025 -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis&
- 김갑성 기자
- 2025-07-15 07:00
StandingTall: Revolutionise Falls Prevention Nationwide with Proven, Scalable Health Tech

SYDNEY, July 15, 2025 -- Miroma Project Factory (MPF), a leader in digital innovation for health and wellbeing, is proud to announce the expanded commercial release of StandingTall, the revolutionary home-based balance training program developed in collaboration with Professor Kim Delbaere, showcasing her life's work in falls prevention. StandingTall is a clinically validated, easy-to-use, and engaging exercise app designed to improve balance, boost confidence, and prevent falls among older adults. Now positioned for widespread adoption, StandingTall offers a proven, scalable s
- 김갑성 기자
- 2025-07-15 06:40

이전

41 42 43 44 45 46 47 48 49 50

많이 본 기사

최근기사

2025-09-04_THU

2025-09-03_WED

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 09월 04일 01시 50분